Management tracks: Impel, InGeneron

Drug delivery company Impel NeuroPharma Inc. (Seattle, Wash.) named Jon Congleton president and CEO. He was president and CEO at Nivalis Therapeutics Inc., which merged with Alpine Immune Sciences Inc. (NASDAQ:ALPN).

Regenerative